US Patent Issued to Saghmos Therapeutics on July 14 for "Prevention and/or treatment of contrast-induced acute kidney injury" (New Jersey, Connecticut Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,435, issued on July 14, was assigned to Saghmos Therapeutics Inc. (Greenwich, Conn.).

"Prevention and/or treatment of contrast-induced acute kidney injury" was invented by Anna Kazanchyan (Weston, Conn.) and Shalini Cornelio (Holmdel, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for preventing, reducing, and/or treating contrast-induced acute kidney injury which include administering an inhibitor of fatty acid oxidation to a patient in need thereof. Also provided are methods involving use of trimetazidine or pharmaceutically acceptable salts thereof for the prevention and/or treatment of contrast-induced acute kidney inju...